Robert S. Rosenson
- Surgery top 10%
- Endocrinology, Diabetes and Metabolism top 5%
- Cardiology and Cardiovascular Medicine top 5%
- Cancer Research
- Epidemiology
- Co-authors
- Daniel GaudetMichael H. DavidsonBenjamin J. HirshSekar KathiresanLawrence BlondeHarold BaysCarlos G. Santos‐GallegoGerald F. Watts
- Topics
- Lipoproteins and Cardiovascular Health (11 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers)Lipid metabolism and disorders (8 papers)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Robert S. Rosenson
20 papers receiving 935 citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Surgery 525
- Endocrinology, Diabetes and Metabolism 368
- Cardiology and Cardiovascular Medicine 359
- Cancer Research 142
- Epidemiology 139
Countries citing papers authored by Robert S. Rosenson
This map shows the geographic impact of Robert S. Rosenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert S. Rosenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert S. Rosenson more than expected).
Fields of papers citing papers by Robert S. Rosenson
This network shows the impact of papers produced by Robert S. Rosenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert S. Rosenson. The network helps show where Robert S. Rosenson may publish in the future.
Co-authorship network of co-authors of Robert S. Rosenson
This figure shows the co-authorship network connecting the top 25 collaborators of Robert S. Rosenson. A scholar is included among the top collaborators of Robert S. Rosenson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert S. Rosenson. Robert S. Rosenson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Durability and efficacy of solbinsiran, a GalNAc-conjugated siRNA targeting ANGPTL3, in adults with mixed dyslipidaemia (PROLONG-ANG3): a double-blind, randomised, placebo-controlled, phase 2 trialbreakdown → | 16 |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 13 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 1 | |
| 8 | Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Riskbreakdown → | 66 |
| 9 | 0 | |
| 10 | 0 | |
| 11 | 132 | |
| 12 | 12 | |
| 13 | 189 | |
| 14 | 82 | |
| 15 | 12 | |
| 16 | 1 | |
| 17 | 2 | |
| 18 | 84 | |
| 19 | 28 | |
| 20 | 217 |
About Robert S. Rosenson
Robert S. Rosenson is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery, having authored 26 papers that have together received 961 indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (11 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers) and Lipid metabolism and disorders (8 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (368 citations), Cardiology and Cardiovascular Medicine (359 citations) and Surgery (525 citations). Robert S. Rosenson has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Daniel Gaudet, Michael H. Davidson, Benjamin J. Hirsh, Sekar Kathiresan, Lawrence Blonde, Harold Bays, Carlos G. Santos‐Gallego, Gerald F. Watts, Paul Muntner and Kausik K. Ray. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.